On Oct 25, major Wall Street analysts update their ratings for $Lam Research (LRCX.US)$, with price targets ranging from $90 to $110.
BofA Securities analyst Vivek Arya maintains with a buy rating.
Barclays analyst Thomas O'Malley maintains with a hold rating, and maintains the target price at $90.
Evercore analyst Mark Lipacis maintains with a buy rating, and adjusts the target price from $113 to $95.
DBS analyst Ling Lee Keng maintains with a buy rating.
B.Riley Financial analyst Craig Ellis maintains with a buy rating, and adjusts the target price from $132.5 to $110.
Furthermore, according to the comprehensive report, the opinions of $Lam Research (LRCX.US)$'s main analysts recently are as follows:
The near-term outcomes for Lam Research were generally in line with expectations, with declines in China being balanced by robust performance in other regions. Nonetheless, this does not answer the broader, more significant long-term inquiries. It is anticipated that Lam will surpass the growth of the wafer fab equipment group in the following year, but there is still a degree of caution regarding the overall market.
Lam Research's modestly better-than-expected results have provided some relief, with near-term concerns around China seemingly having been mitigated to an extent. The stock might continue to experience limited price movement until there is greater transparency regarding China's restrictions and the anticipated growth of the WFE market by 2025.
Here are the latest investment ratings and price targets for $Lam Research (LRCX.US)$ from 5 analysts:
Note:
TipRanks, an independent third party, provides analysis data from financial analysts and calculates the Average Returns and Success Rates of the analysts' recommendations. The information presented is not an investment recommendation and is intended for informational purposes only.
Success rate is the number of the analyst's successful ratings, divided by his/her total number of ratings over the past year. A successful rating is one based on if TipRanks' virtual portfolio earned a positive return from the stock. Total average return is the average rate of return that the TipRanks' virtual portfolio has earned over the past year. These portfolios are established based on the analyst's preliminary rating and are adjusted according to the changes in the rating.
TipRanks provides a ranking of each analyst up to 5 stars, which is representative of all recommendations from the analyst. An analyst's past performance is evaluated on a scale of 1 to 5 stars, with more stars indicating better performance. The star level is determined by his/her total success rate and average return.
美東時間10月25日，多家華爾街大行更新了$泛林集團 (LRCX.US)$的評級，目標價介於90美元至110美元。
美銀證券分析師Vivek Arya維持買入評級。
巴克萊銀行分析師Thomas O'Malley維持持有評級，維持目標價90美元。
Evercore分析師Mark Lipacis維持買入評級，並將目標價從113美元下調至95美元。
星展銀行分析師Ling Lee Keng維持買入評級。
萊利金融分析師Craig Ellis維持買入評級，並將目標價從132.5美元下調至110美元。
此外，綜合報道，$泛林集團 (LRCX.US)$近期主要分析師觀點如下：
拉姆研究的短期業績通常符合預期，在中國的下降有所平衡，而其他地區的表現強勁。然而，這並不能回答更廣泛、更重要的長期問題。預計拉姆將在接下來的一年裏超越晶圓廠設備組的增長，但對整體市場仍然存在一定程度的謹慎。
拉姆研究的結果略優於預期，爲人們提供了一些緩解，儘管近期對中國的擔憂似乎已經在一定程度上得到緩解。直到關於中國限制措施的透明度以及WFE市場到2025年預期增長更加透明之前，股價可能會繼續經歷有限的價格波動。
以下爲今日5位分析師對$泛林集團 (LRCX.US)$的最新投資評級及目標價：
提示:
TipRanks為獨立第三方，提供金融分析師的分析數據，並計算分析師推薦的平均回報率和勝率。提供的信息並非投資建議，僅供参考。本文不對評級數據和報告的完整性與準確性做出認可、聲明或保證。
TipRanks提供每位分析師的星級，分析師星級代表分析師所有推薦的過往表現，通過分析師的總勝率和平均回報率综合計算得出，星星越多，則該分析師過往表現越優異，最高爲5颗星。
分析師總勝率為近一年分析師的評級成功次數占總評級次數的比率。評级的成功與否，取決於TipRanks的虚擬投資組合是否從該股票中產生正回報。
總平均回報率為基於分析師的初始評級創建虚擬投資組合，並根據評級變化對組合進行調整，在近一年中該投資組合所獲得的回報率。
